143 results on '"Goad, Jeremy"'
Search Results
2. Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma
3. Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up
4. Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial
5. Targeted Prostate Health Checks, a novel system to identify men with prostate cancer—A pilot study.
6. Indocyanine green in minimally and maximally invasive genitourinary cancer surgery
7. The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology
8. Supplementary Figure 1 from Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis
9. Supplementary Materials, Methods and Figure 1 from Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis
10. Developing and evaluating Robocare; an innovative, nurse-led robotic prostatectomy care pathway
11. Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose–response relationship
12. Role for a Web-Based Intervention to Alleviate Distress in People With Newly Diagnosed Testicular Cancer: Mixed Methods Study
13. Changing face of robot‐assisted radical prostatectomy in Melbourne over 12 years
14. A meta-analysis of clinicopathologic features that predict necrosis or fibrosis at post-chemotherapy retroperitoneal lymph node dissection in individuals receiving treatment for non-seminoma germ cell tumours
15. Assessing the Impact of an Online Intervention (Nuts & Bolts) on Distress for People with Newly Diagnosed Testicular Cancer using a Mixed Methods Approach (Preprint)
16. Additional file 1 of Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up
17. A case of acute-colonic pseudo-obstruction (Ogilvie Syndrome) post robot-assisted radical prostatectomy
18. Patterns-of-care and health economic analysis of robot-assisted radical prostatectomy in the Australian public health system
19. ACCURACY OF ULTRASONOGRAPHY FOR THE EVALUATION OF UROLITHIASIS IN PATIENTS UNDERGOING EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY: COMPARISON WITH NON-CONTRAST COMPUTED TOMOGRAPHY: MP54-20
20. EARLY EXPERIENCE OF ROBOTIC SALVAGE PELVIC LYMPH NODE DISSECTION IN THE GA-68 PSMA PET SCANNING ERA: V4-07
21. Large and rapid local recurrence of clear cell renal cell carcinoma
22. Patients with medical risk factors for chronic kidney disease are at increased risk of renal impairment despite the use of nephron-sparing surgery
23. The dilemma of distance: patients with kidney cancer from regional Australia present at a more advanced stage
24. Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival
25. A meta-analysis of clinicopathologic features that predict necrosis or fibrosis at post-chemotherapy retroperitoneal lymph node dissection in individuals receiving treatment for nonseminoma germ cell tumours.
26. Stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumors: The RAPPORT trial.
27. MP64-09 DUCTAL ADENOCARCINOMA OF THE PROSTATE IS ASSOCIATED WITH SHORTER METASTASIS-FREE SURVIVAL
28. Anterior prostatectomy for the excision of bladder paraganglioma with prostatic invasion: a unique case of partial prostatectomy
29. Re: Dilemma of small renal masses
30. LAPAROSCOPIC PARTIAL NEPHRECTOMY: INTEGRATION OF AN ADVANCED LAPAROSCOPIC TECHNIQUE
31. Intractable acute ischaemic priapism occurring secondary to newly commenced olanzapine
32. Assessment of a European Bladder Cancer Predictive Model for Non-Muscle Invasive Bladder Cancer in an Australian Cohort
33. The frequency of apoptosis correlates with the prognosis of Gleason Grade 3 adenocarcinoma of the prostate
34. Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy
35. Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial
36. BCG immunotherapy for non-muscle invasive bladder cancer: is efficacy related to toxicity?
37. Changing face of robot-assisted radical prostatectomy in Melbourne over 12 years
38. PD53-10 IMPACT OF ADJUVANT TREATMENT ON LONG-TERM QUALITY OF LIFE OF TESTICULAR CANCER SURVIVORS
39. BCG immunotherapy for non-muscle invasive bladder cancer: is efficacy related to toxicity?
40. Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma
41. V4-07 EARLY EXPERIENCE OF ROBOTIC SALVAGE PELVIC LYMPH NODE DISSECTION IN THE GA-68 PSMA PET SCANNING ERA
42. MP54-20 ACCURACY OF ULTRASONOGRAPHY FOR THE EVALUATION OF UROLITHIASIS IN PATIENTS UNDERGOING EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY: COMPARISON WITH NON-CONTRAST COMPUTED TOMOGRAPHY
43. Migration of an established pre‐operative education session for robot‐assisted radical prostatectomy patients to telehealth: A quality improvement initiative.
44. Patterns-of-care and health economic analysis of robot-assisted radical prostatectomy in the Australian public health system
45. Massive haemorrhage post-extracorporeal shockwave lithotripsy resulting in nephrectomy: a case report
46. Tumor-Induced Activation of Lymphatic Endothelial Cells via Vascular Endothelial Growth Factor Receptor-2 Is Critical for Prostate Cancer Lymphatic Metastasis
47. Risk Factors for Urinary Incontinence after Radical Prostatectomy
48. In Reply
49. Radical Retropubic Prostatectomy: Limited Benefit of Autologous Blood Donation
50. Radical Retropubic Prostatectomy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.